or Try an Advanced Search...

    Akseli Hemminki Stocks List

    Symbol Grade Name % Change
    REPL B Replimune Group, Inc. 1.19
    CLDI D Calidi Biotherapeutics, Inc. 14.42
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Biotechnology Cancer Oncolytic Virus Solid Tumors Virotherapy Cancer Immunotherapy Cancer Treatment Cell Biology Cell Therapy Clinical Medicine Experimental Cancer Treatments Glioma Immune System Immunotherapy Immunotherapy Products Medicine Metastatic Disease Rp1 Stem Cell Transgene Sa

    Related ETFs - A few ETFs which own one or more of the above listed Akseli Hemminki stocks.

    Symbol Grade Name Weight
    CNCR F Loncar Cancer Immunotherapy ETF 1.55
    BBC B Virtus LifeSci Biotech Clinical Trials ETF 1.0
    MEDX D Horizon Kinetics Medical ETF 0.99
    PTH D Invesco DWA Healthcare Momentum ETF 0.79
    SBIO B ALPS Medical Breakthroughs ETF 0.53
    View all Akseli Hemminki ETFs...
    Compare ETFs
    Compare CNCR to PTH Compare MEDX to SBIO Compare PTH to SBIO

        Akseli Hemminki Stocks Recent News

        Date Stock Title
        Oct 30 REPL Replimune to Present at the 39th Annual Meeting of the Society for Immunotherapy of Cancer (SITC)
        Related Industries: Biotechnology
        Related Stock Lists: Biotechnology Cancer Oncolytic Virus Solid Tumors Virotherapy Cancer Immunotherapy Cancer Treatment Cell Biology Cell Therapy Clinical Medicine Experimental Cancer Treatments Glioma Immune System Immunotherapy Immunotherapy Products Medicine Metastatic Disease Rp1 Stem Cell Transgene Sa
        Akseli Hemminki

        Akseli Hemminki (1973-07-27) July 27, 1973 (Helsinki) is a Finnish specialist in Oncology and Radiotherapy, Professor of Oncology and founder of two biotechnology companies.

        More about Akseli Hemminki
        Browse All Tags